Sage Journals: Discover world-class research

Abstract

Background:

This study considers how the COVID-19 pandemic impacted individuals recovering from a substance use disorder (SUD).

Method:

Fifty individuals recovering from SUD in Vermont, a rural New England state (U.S.), were recruited for an interview from 12-step recovery meetings (Alcoholics Anonymous, Narcotics Anonymous) as well as via word-of-mouth. Interviews were transcribed and coded, and qualitative analyses were performed.

Results:

Many of the participants who were in recovery prior to the pandemic starting remained substance-free and in recovery throughout the pandemic period. Some individuals used substances during the pandemic period, although not typically in the context of a relapse caused by negative emotions (eg, distress over a loved one contracting COVID-19). The majority of those individuals indicated that the risk of catching COVID-19 did not alter their substance use.

Conclusions:

Many individuals already in SUD recovery before COVID-19 remained in recovery despite the challenges of pandemic era. The role of peer support in recovering individuals managing negative emotions caused by COVID-19 is considered.

Keywords

Substance use disorder recovery relapse COVID-19 pandemic

Introduction

This study examines how the COVID-19 pandemic with its social distancing requirements affected people recovering from a substance use disorder (SUD). Recovering from SUD was defined as the use of substances (eg, alcohol, marijuana, cocaine) that had crossed a line from use to abuse, and had begun to severely and negatively impact the individual’s life (work, relationships) such that they felt a need to seek out assistance to halt their abuse. This research considers the COVID-19 pandemic as a mass trauma-inducing experience^1
-5 likely to have disrupted and harmed individuals’ recovery efforts. The COVID-19 virus upended all areas of life. Activities that would normally be undertaken indoors – work, events, school – shifted to remote participation; or in-person, socially distanced, masked-up events. This includes attendance at 12-step recovery meetings.

This paper explores how recovering individuals fared during the pandemic, emotions during the pandemic period, and whether study participants relapsed. An earlier paper⁶ of some preliminary findings – specifically participants’ feelings about whether the terms “addict” and “alcoholic” are stigmatizing – was published in Substance Abuse: Research & Treatment in 2023. The findings presented in the current paper are different from those in the 2023 article.

Literature Review

Substance use among adults,^7
-9 relapse¹⁰ and drug overdoses¹¹ increased during the pandemic. Pandemic-era stress and anxiety, combined with disruption to treatment programing, increased the risk of substance misuse and relapse.¹² A 2020 survey by the Addiction Policy Forum¹³ of individuals with a substance use disorder (n = 1079) found that one-third of respondents experienced disruptions to recovery services during the pandemic. Among respondents’ concerns were the lack of access to support group meetings, including 12-step fellowship meetings.¹³

Other research¹⁴ found that some recovering individuals adapted to lock-down protocols by substituting one addiction (eg, alcohol) for another (pornography). In addition to the heightened risk of catching COVID-19 as compared to people that do not use substances,¹⁵ individuals with SUD also face greater health and mental health issues^6,16 (eg, mood disorders, depression, anxiety, overdose). Social distancing requirements presented challenges for recovering individuals,¹⁷ whose recovery may depend on in-person support from peers.^18,19 Strong social networks are a key to substance use recovery.²⁰ Economic and social shifts caused by COVID-19 adversely impacted access to treatment for substance abusing individuals, likely worsening their addictions.^21,22 In a 2022 study¹¹ of 21 U.S.-based drug treatment and harm reduction programs, individuals receiving treatment reported a 27% point reduction in group counseling meetings. The pandemic necessitated outpatient clinics reducing the number of in-person appointments, compounding an already existing gap in treatment implementation.⁸

One question the PI had at the onset of the study was whether individuals with pre-COVID-19 fragile recovery status (ie, the person often thought about substances and felt “on the fence” about whether they would continue to abstain from using alcohol or drugs) would be more likely to relapse, either due to the inability to attend meetings in person or because of negative emotions. Prior research²⁰ found that while some participants in a harm reduction program experienced isolation and loneliness during the pandemic, others found that isolating nature of the COVID-19 era was peaceful and lowered their stress. Continuing in this vein, it is plausible that some participants in the present study would feel similarly; that is, some would feel lonely and anxious while others would feel at peace.

This study also considered whether strong negative emotions about COVID-19 and all that came with it (eg, closing of in-person AA/NA meetings, sheltering in place) influenced any relapse with substances. Past research²³ has shown high levels of lifetime trauma among individuals seeking treatment for opioid addiction. As per one prior study,²⁴ the vast majority of patients recovering from a substance use disorder had experienced at least one traumatic event; and that relapse with substances was more common among individuals with past histories of interpersonal violence victimization. Qualitative research²⁵ on individuals seeking treatment for a substance use disorder, who also had untreated post-traumatic stress disorder, found that the patients craved substances and self-medicated after a trauma trigger. A 2021 review²⁶ of research found that the brain’s prefrontal cortex is “involved in drug seeking behavior as well as the extinction of fear conditioning, playing a role in both addiction” and post-traumatic stress disorder. The author’s own prior research²⁷ suggests that a past trauma experience increases individuals’ smoking.

The present study considered how the COVID-19 pandemic impacted individuals recovering from substance addiction. The study also makes the novel contribution of examining how individuals who continued to use substances during the pandemic navigated the risk of catching COVID-19 while acquiring drugs or alcohol.

Method

Sampling

Fifty individuals recovering from a substance use disorder were interviewed by the PI over the course of 18 months, beginning in June 2022 and concluding in December 2023. A primarily purposive sampling approach was employed with the goal of recruiting as many individuals as possible within the study timeframe. The PI also asked participants if they knew anyone else recovering from SUD to whom they would recommend the PI reach out (ie, snowball sampling). The study was primarily qualitative in nature, and in keeping with other qualitative research aimed to shed light on the diversity and nuances of different individuals’ experiences. Saturation of themes and insights in qualitative research is achieved around the 24th interview.²⁸

Participant recruitment

Participants were recruited by the PI from different socio-economic areas throughout Vermont, a rural state²⁹ in the New England region of the United States. The PI announced the study at 12-step meetings of the Narcotics Anonymous (NA) and Alcoholics Anonymous (AA) fellowships that were classified as open to the public. In other words, an attendee (eg, the study’s PI) did not need to be in recovery themselves to attend. Twelve-step meeting locations and times were gathered through two apps downloaded to the PI’s phone. The PI also hung informational flyers about the study in recovery centers and clubhouses where 12-step meetings sometimes convene. The decision to recruit from 12-step meetings was made because they are widely available and easily accessible throughout the state, and a key element of these types of fellowships is support from fellow recovering people. A fundamental part of these types of fellowships was likely to be greatly impacted by the mandated closure of in-person meeting facilities such as churches and clubhouses.

A $20 Amazon gift card was offered to participants as an incentive to be interviewed. It should be noted that individuals did not have to be 100% substance-free in order to enroll in the study. As long as they self-identified as being in recovery, they were eligible to enroll as a participant. Any subject who had seemed under the influence of a substance at the time of the interview would have been excluded. (This did not happen.) Interviews took place in a variety of locations (eg, coffee shops, libraries), with the participants’ comfort level being the main consideration in choosing a day, time and location to conduct the interview.

Informed Consent

Approval from the university’s institutional review board (IRB) was received in advance of participant recruitment starting. Participants were given two copies of a written informed consent form, one to keep, and the other to read, sign and return to the PI. At the conclusion of interviews participants were handed a written debriefing form, reviewing the purpose of the study and including contact information for the PI as well as the PI’s university’s IRB.

Interview protocol

All interviews were conducted by the study’s PI. No other individuals were present for the interviews. While some interviews took place in public settings (eg, coffee shops), the PI made an effort to secure a table not too close to other people present in the setting. The PI also double-checked with the participant that they were comfortable with the location for the interview. Interviews took on average 25 minutes, although the length varied depending on how talkative a participant was. The shortest interview was 9 minutes long and the longest interview lasted for 62 minutes. Subjects were asked about how their recovery experience was during the pandemic period. They were asked about substances they had use(d) (ie, tobacco, marijuana, alcohol, heroin, opioids, cocaine, methamphetamines, and “other” drugs); and whether and how their substance use patterns changed during the pandemic. Respondents were asked about how solidly they felt they were in recovery both at the time of the interview and before COVID-19; and if they relapsed with any substances during the COVID-19 period. For individuals that did relapse, they were asked about which factors of the COVID-19 era contributed to their relapsing.

To account for COVID-19 as a traumatic event, items informed by trauma symptom instruments such as the Trauma Symptom Inventory^30,31 were included. (A copy of the interview protocol is included as an Supplemental Appendix to this paper.) For individuals that did relapse, or had not yet begun their recovery at the time of COVID-19, they were asked about experiences acquiring substances during the pandemic (eg, if the risk of contracting COVID-19 made them hesitate). Respondents were also asked about their fear, if any, of contracting COVID-19; and how this may have impacted their participation in recovery, and/or (if applicable) their seeking out drugs for a relapse. The perseverance to access substances despite environmental risks was of interest. In a study⁹ of Canadian people who use drugs (PWUD), among those who continued to use drugs during the COVID-19 era, the PWUD reported changes in their drug supply (eg, contamination) – and yet they persisted in seeking out drugs, underscoring the powerful pull of addiction.

The “COVID-19-as-a-traumatic-event” related questions (see Supplemental Appendix) were informed by existing trauma instruments.^30,31 Other protocol questions were originally written by the study PI based on her prior research on substance addiction. Questions were grounded in the study’s research questions, and were pilot tested with three recovering individuals (not part of the study’s sample) who attend 12-step meetings in advance of going “live” with the interviews.

Participants were not initially asked for their age as it was not directly relevant to the study’s questions. It became apparent at the mid-study reporting point that the study’s funder, the National Institutes of Health, was requesting certain demographic data including age. The PI thus backed into the participant database and retroactively added estimated ages. From that point forward, the PI continued to record estimated age ranges (or enter an exact age, if the participant proactively volunteered their age). For continuity, the PI opted not to start asking future interviewees their age, as this had not been done with past participants.

Data, coding and qualitative analyses

Subjects’ interviews were recorded and then transcribed using an outside transcription service. Participants’ answers to open-ended questions were coded using a code list created based on the interview protocol using Atlas Ti qualitative analysis software, which has been used in other qualitative public health research.^32,33 Coding from a code list is an initial step in conducting a content analysis^34,35 of responses to open-ended questions (eg, “How would you say COVID-19 and everything that came with it [sheltering in place] affected you in your recovery?”). The broad code list for the qualitative data (words and phrases from the interviews) was as follows: recovery status-now, recovery status-pre-COVID-19, trauma, emotions. Three student research assistants independently performed the initial coding of the qualitative data (ie, words and phrases) in the transcripts, and for interrater reliability reviewed each other’s coding. The PI then checked the research assistants’ coding. Once all the transcripts were coded, the PI performed searches in Atlas Ti on the various codes, looking for common themes.

Results

Participants

Twenty-nine participants were male and 18 were female. Three individuals self-identified as gender fluid or transgender. Forty-eight of the subjects were Caucasian, in keeping with the primarily Caucasian state population. The mean age range was 40s, although subjects ranged from being in their 20s to being in their 70s. The youngest participant was 21 years old. Forty percent of the participants said they attend AA exclusively; 30% attend NA exclusively; and 20% indicated that they attend both 12-step fellowships. Five participants use other or additional mechanisms (eg, therapy, church) to support their recovery. Eight percent of the sample indicated that they currently or in the past participate in medication-assisted treatment such as using doctor-prescribed suboxone to ease addiction to an opioid such as fentanyl or heroin. The mean age of respondents starting to use substances was 16 years old. Respondents had used substances for various lengths of time, for as short as 2.5 years to as long as 54 years.

Recovery status

Individuals’ length of time in recovery ranged from short (under 1 year) to long (10 years or longer; see Table 1 below). How an individual conceptualized being “in recovery” was left to them, but generally corresponded with their initial efforts to stop or reduce their use of substances, sometimes with 12-step fellowship support and other times not. Being in recovery was not framed as being the same thing as being substance-free. For instance, some participants indicated that they had been on their recovery journey for many years, but had relapsed with substances a few months prior. One participant said that she had two recovery dates, the first for when she stopped using heroin and transitioned to using suboxone; and the other – her “real” recovery date – when she got off suboxone for good.

Table 1.

Length of time in recovery.

Length of time in recovery	Number*	Percent
Less than1 y	12	24%
1-5 y	11	22%
5-10 y	6	12%
Over 10 y in recovery	20	40%

Information is not available for one individual.

Alcohol and marijuana were the most commonly used substances over the course of participants’ lifetimes. The majority of respondents had used or did currently use tobacco, primarily cigarettes. Other substances used included prescription drugs, Quaaludes, secobarbital, inhalants (eg, huffing nitrous), “a lot of different pills. . . like benzos,” angel dust, Ritalin, amphetamines, Adderall, and Xanax. Preferred substances were across the board and included alcohol, cocaine, crack cocaine, marijuana, heroin, opioids, pain killers, and valium.

The majority of respondents (80%) classified their current recovery status as stable. Related comments included “fairly solid. . . the past four years have pretty much been the best four years of my life”; “I have a pretty good foundation”; “I’m very involved in my recovery”; “I’m pretty solid now”; “my recovery right now is more solid than it has been for years.” A smaller number of respondents described their current recovery status as less stable, mentioning things like “definitely pretty shaky”; “I’ve had the worse things in my life happen to me in the last four years”; “I’m a pretty miserable human being”; and “I’d say somewhere in between. There’s definitely days where I’m, like, a problem arises, I’m like, what? I’d rather just smoke or get high.”

Impact of the pandemic on recovery and substance use

Many participants had negative comments about the impact of COVID-19 on their recovery (see Table 2, below). Others also provided some positive perspective about the time, and/or that the pandemic was minimally impactful on their recovery and life.

Table 2.

Impact of the pandemic on recovery.

Negative impacts of COVID-19 on recovery	Positive or minimal impacts of COVID-19 on recovery
“I certainly felt the social isolation.”	“It didn’t affect me much because I live alone anyway and I’m alone most of the time. My wife and I are separated. So it wasn’t so different for me.”
“I really missed people-to-people contact.”	“I had been sober before the pandemic so it helped me through the pandemic.”
“I had a lot of cravings, and just felt a lot of triggers and stuff. And then, you know, in the last year or two unfortunately last year I lost my mother, so that went on for like a year. So yeah, that’s pretty triggering.”	“Clearly the use of Zoom and how AA found its way is a miracle about how recovery works is what I would say. I really feel like that was a lifesaver to my personal happiness. And, you know, I saw people get sober on Zoom. It’s truly amazing.”
“I started to isolate and really pull away from recovery as a whole. Stopped going to meetings, stopped calling my sponsor. . . definitely felt like my addictive behaviors were increasing.”	“I would say it [COVID-19] benefited my recovery. I don’t have a history of being active in AA in face-to-face meetings. I don’t have a sense that I’m missing something.”
“Before the pandemic began I attended more meetings. I felt like I had more of a connection with the people in recovery.”	The number of people that I worked with and interacted with was definitely reduced, but it wasn’t, it wasn’t like I was secluded from anybody.
“Upon getting sober during quarantine, I just had nothing to do. ‘Cause that [drinking] was my only pastime, really, it was getting drunk and playing guitar and then it was just being sober and playing guitar. So it was really hard.”
“It [COVID-19] forced me to go back into isolation, which is my danger zone. And as the pandemic started lifting, like I didn’t want to be around people. Which again, for me, for this addict, is a very difficult place to be because that’s where my journey started, in isolation.”

Of the fourteen individuals who used substances during the pandemic, most indicated that they sought out substances regardless of the risk of catching COVID-19. A few individuals said that the risk of catching COVID-19 impacted their seeking out and abusing substances in that they decreased their use. Examples of comments are shown in Table 3.

Table 3.

Impact of the pandemic on substance use.

Continued substance use during COVID-19	Decreased substance use during COVID-19
“I just went to the same guy who lived right down the road from me. There wasn’t nothing else to do [during COVID-19]. We just smoked weed and played Call of Duty, which, at the time, just seemed normal for people our age.”	“I was less likely to go and mingle and hang out with a bunch of people I knew may be sick.”
“I could’ve called and been like ‘Hey, you good?’ and if he was like, ‘Yeah, I’m good but I have COVID’ that wouldn’t have stopped me for a second.”	“I’d find somewhere else to go get it because I knew that person had COVID.”
“I never honestly took it [COVID-19] super serious.”	“It was more difficult but not impossible to find substances.”
“My thought automatically went to, ‘Are they gonna close the liquor stores? Am I gonna not be able to go to bars anymore?’”
“No, it didn’t affect me at all. I was living with a cocaine dealer.”
“It [COVID-19] definitely increased my use exponentially.”
“Yeah, it [COVID-19] made me want to get high more because I was really scared about what’s happening, what’s going on. Getting high was the only thing that I had control over.”
“Once the pandemic hit and we were shut in, my drinking took off because liquor stores were open.”
“I could sneak around a lot more and get away with my use” [while his wife was sick with COVID-19 and quarantining]

Emotions during the COVID-19 pandemic

As seen in Table 4, the majority of respondents indicated they had felt anxious, sad, and depressed often or sometimes during the pandemic period. More than half indicated that they felt lonely. Fewer respondents said they sometimes or often felt “anger” emotions (ie, rage, wanting to hurt someone).

Table 4.

Emotions during COVID-19.

Emotions during COVID-19	Number responding sometimes or often	Percent responding sometimes or often
Anxious	37	74%
Sad	30	60%
Depressed	30	60%
Lonely	29	58%
Rage	18	36%
Wanting to hurt someone	5	10%

In terms of other emotions during the pandemic, participants mentioned some negative feelings: “disconnected,” “worthlessness,” “isolated,” “I have a history of self-harm and I did end up cutting a couple of times,” “suicidal thoughts,” “frustrated and burnt out,” “powerlessness,” “uncomfortable,” “completely overwhelmed,” “chronic stress.” As one respondent explained, “I was already anxious and depressed and a nervous wreck in my life, and then the pandemic happened. The world’s never going to be the same, and how am I going to cope with this?” Participants also mentioned positive feelings: “gratitude,” “excitement sometimes,” “a peaceful time,” “happy,” “we were getting first access to vaccines,” “relief that I didn’t get sick,” “sense of hope.”

Emotions and (thoughts of) relapse

Eleven participants (n = 11) indicated that they had had a recent relapse. While subjects expressed a variety of pandemic-era emotions, only three individuals connected their emotions to a subsequent relapse. As one participant explained, “Yeah, that [drinking] was like the most helpful thing for me at the time [when their friends were sick with COVID-19] because there was no real like support that I felt. . . those resentments built too, and then wanting relief from that kind of validated my [alcohol] use at the time.” Another interviewee thought about relapsing, but did not end up turning to substances, because of fears for their mother. “My biggest fear before she actually did pass away was my mom passing away. . . . I was in Vermont, not in San Diego yet when she had it, and just knowing her health and stuff, yeah, it was definitely triggering [of wanting to use drugs].” Another participant explained that turning back to alcohol provided some comfort during the pandemic “because there was no real support that I felt [for front-line workers]. I also felt really misunderstood and really taken for granted.” One participant explained that while they did not end up relapsing, they began to have “very vivid dreams” about relapsing. “During the COVID pandemic, I started having dreams about use to the point where I’d wake up and I can still taste the drug. You know, I used to snort meth and there’s this taste. . . . I mean, the taste is that vivid. And so, there were times that I really had crystal clear vivid dreams that I haven’t had in a long time. The only thing I can think of is stress.”

Emotions around loved ones contracting COVID-19

Slightly more than half of the sample caught COVID-19, and nearly everyone had friends or family that had contracted the virus. In describing how their friends and family catching COVID-19 affected them emotionally, subjects’ responses tended to fall into one of two categories. First, some comments reflected the fact that loved ones’ illnesses weren’t that serious. “All the people that I know that got it didn’t really act like it was that big of a deal.” “Nobody I knew was hospitalized and dying.” “I wasn’t ever super worried thankfully.” “Everyone seemed like they would be alright.” “It was tough but I knew she would be okay.” “Wasn’t too bad.” Second, other comments expressed more painful emotions. “My dad was in the ICU and it was horrible.” “Concerned.” “I did worry about my mom a little bit catching it.” “I felt really bad for my children. It hurt me that they were in so much pain and there was nothing that I could do about it.” “It was frightening.” “It was really scary, and really anxiety-inducing fearing that I might possibly lose these people that I really care about, like my dad and my sister.” “Terrible. This is just a layer of stress. Terrible because I’m not a doctor. I don’t know what to do.”

Discussion

This study examined the impact of the COVID-19 pandemic and everything that came with it (eg, sheltering in place) on the substance use recovery experience. There are a number of key findings. First, in terms of the pandemic’s impact on recovering individuals, while COVID-19 presented challenges, many of the respondents maintained their recovery throughout the pandemic period. Some participants did not experience much of a COVID-19 impact on their recovery, either because they had a strong pre-COVID-19 recovery foundation, were used to being alone, or got into recovery during the pandemic period and had never experienced in-person meetings and as such had no sense of losing something. These findings echo those of Smith et al²⁰ who determined that while some patients in a harm reduction program felt lonely and isolated during the pandemic, others found that isolating nature of the COVID-19 era to be peaceful and stress-lowering.

While the majority of participants felt their recovery was solid at the time of the interview, some individuals continued to use substances during the pandemic period. The majority of those individuals indicated that the risk of catching COVID-19 did not alter their substance use behavior (eg, going to the liquor store, going to a dealer to purchase drugs). Counter to expectation, the author did not find strong evidence of relapse with substances stemming from negative or trauma emotions caused by the pandemic, although this may partly be due to recruitment and sampling of participants from 12-step recovery programs. Individuals not actively pursuing recovery from a substance use disorder would not have crossed paths with the PI. These findings are counter to those of some existing research which found substance relapse (Dror et al¹⁰) and substitution of one addiction for another (Sinclair et al¹⁴) during the pandemic. Results suggesting that the negative emotions of the pandemic era did not seem to cause substance relapse has the caveat that this was not a formally tested hypothesis. While some participants actively used substances during all or part of the pandemic, most had already been in the habit of doing so, as opposed to having succumbed to an emotionally triggered relapse.

This study is part of a body of research on the myriad emotions processed by individuals recovering from a substance use disorder during a traumatic time in life.^23
-25 In a qualitative study²⁵ of patients with comorbid substance use disorder and posttraumatic stress disorder, patients sometimes relapsed with substances following a trauma intrusion when they saw no other avenue for coping with their emotions. In contrast, participants in the current study experienced both negative feelings (frustration, stress) and positive emotions (gratitude, sense of hope). This may be due to the peer support offered through 12-step programs, which continued to exist albeit in a virtual format.

Limitations

As with any research study, there are a number of limitations that must be acknowledged. The results presented are based on qualitative analyses of data from a modest sample (50 individuals) recruited primarily from 12-step recovery fellowships. The biggest challenge to conducting the study was subject recruitment. Given the rural nature of Vermont, the long geographical distance to some 12-step meetings, and massive rains and subsequent flooding of cities that occurred during the summer of 2023, participant recruitment remained challenging throughout the study period. Even with the $20 Amazon gift card as an incentive, some prospective subjects – men in particular – remained wary about being interviewed, or initially agreed and then changed their mind. Additionally, individuals still struggling with addiction and not actively seeking recovery would not have been candidates for the study. As such, the findings cannot easily be generalized to the larger population of individuals dealing with a substance use disorder.

It should also be acknowledged that the interview protocol was originally created for this study and not previously validated through prior research, although the trauma emotion questions were informed by existing trauma scales,^30,31 as was mentioned in the method section. The reason for creating original questions was that the pandemic was a new event and no interview protocols existed that asked about specifically what the PI wanted to know. The interview protocol was pilot tested with three recovering individuals (not part of the study’s sample) in advance of the study “going live.”

Finally, while the PI believes that a sample size of 50 is sufficient to achieve saturation of the study’s main themes and question – the impact of the COVID-19 pandemic on individuals’ substance abuse recovery journey – a formal power calculation regarding sample size was not conducted as it is unusual to do so with a qualitative study. A review of prior literature²⁸ on sample size in qualitative research supports the sufficiency of a sample of 50 recovering individuals for an interview project of this nature.

Implications for Practitioners

While some research^36,37 has found that 12-step fellowships lack effectiveness in reducing substance use, the present study suggests that individuals participating in 12-step meetings may access resources (eg, peer support) that are helpful in managing negative emotions, which may in turn contribute to non-relapse during a trying period. The pandemic is but one difficult life event, and an individual recovering from substance addiction may also experience divorce, death of a loved one, or job loss – all of which can cause acute distress and threaten one’s recovery. Having similarly situated peers to share the pain with can help alleviate the distress. In keeping with the National Institutes of Health current framework, being “clean” (ie, drug and/or alcohol free) frames recovery in a stigmatizing way³⁸ and is not necessarily reflective of an individual’s recovery journey, which may involve multiple relapses while a person nonetheless remains tethered in some small or large way to network of recovering peers. Even if a person has a “slip” with substances, having a support network of non-judgmental friends may help bring them back to recovery sooner. Participation in 12-step fellowship meetings is an option as a sort of low-cost outpatient recovery resource³⁹ that can connect individuals with a support network.

Supplemental Material

sj-docx-1-sat-10.1177_29768357241287405 – Supplemental material for The Impact of the COVID-19 Pandemic on Recovery From Substance Use Disorder: Findings From a Qualitative Study

Supplemental material, sj-docx-1-sat-10.1177_29768357241287405 for The Impact of the COVID-19 Pandemic on Recovery From Substance Use Disorder: Findings From a Qualitative Study by Connie Hassett-Walker in Substance Abuse: Research and Treatment

Supplemental Material

sj-docx-2-sat-10.1177_29768357241287405 – Supplemental material for The Impact of the COVID-19 Pandemic on Recovery From Substance Use Disorder: Findings From a Qualitative Study

Supplemental material, sj-docx-2-sat-10.1177_29768357241287405 for The Impact of the COVID-19 Pandemic on Recovery From Substance Use Disorder: Findings From a Qualitative Study by Connie Hassett-Walker in Substance Abuse: Research and Treatment

Supplemental Material

sj-pdf-3-sat-10.1177_29768357241287405 – Supplemental material for The Impact of the COVID-19 Pandemic on Recovery From Substance Use Disorder: Findings From a Qualitative Study

Supplemental material, sj-pdf-3-sat-10.1177_29768357241287405 for The Impact of the COVID-19 Pandemic on Recovery From Substance Use Disorder: Findings From a Qualitative Study by Connie Hassett-Walker in Substance Abuse: Research and Treatment

Footnotes

Acknowledgements

The PI is grateful to all the study participants for sharing their recovery experiences during the pandemic with the PI. The author is also grateful to her colleagues at the Vermont Biomedical Research Network for their ongoing support of this research. The PI expresses gratitude to the study’s student research assistants for their work in coding the interview transcripts.

Author Contribution

The PI is the sole author of the manuscript and is responsible for 100% of the analyses presented, and the writing of the manuscript.

Funding:

The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103449 to the Vermont Biomedical Research Network (VBRN). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NIH or VBRN.

Declaration of conflicting interests:

The author declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Connie Hassett-Walker, the study PI and author of the paper, has no conflicts of interest in conducting this study or writing this manuscript.

Ethical Approval

The study was initially approved by the PI’s Institutional Review Board on November 30, 2021. Two IRB renewals were sought and obtained on December 19, 2022 and again on January 2, 2024. All participants received and signed written informed consent forms prior to being interviewed.

Informed Consent

Approval from the Norwich University’s institutional review board (IRB; IRB #00005859) was received in advance of participant recruitment starting. Participants were given two copies of an informed consent form, one to keep, and the other to read, sign and return to the PI.

The chair of the Norwich University IRB is Dr. Mark Stefani, mstefani@norwich.edu. Additional information about the Norwich University IRB can be requested from IRB@norwich.edu. Address: Norwich University, 158 Harmon Drive, Jackman Hall 325, Northfield, Vermont 05663.

IRB Statement

This study was approved in advance by the Norwich University Institutional Review Board (IRB; IRB #00005859) on November 30, 2021. Two IRB renewals were sought and obtained on December 19, 2022 and again on January 2, 2024. The chair of the IRB is Dr. Mark Stefani, mstefani@norwich.edu. Additional information about the Norwich University IRB can be requested from IRB@norwich.edu. Address: Norwich University, 158 Harmon Drive, Jackman Hall 325, Northfield, Vermont 05663.

Trial Registration Number/Date

Not applicable

ORCID iD

Dr. Connie Hassett-Walker

Data Availability Statement

A deidentified version of the database used in the analyses of this paper is available upon request from Dr. Connie Hassett-Walker (chassett@norwich.ed), with approval from Dr. Mark Stefani (mstefani@norwich.edu), Chair of the Norwich University Institutional Review Board (IRB@norwich.edu).

Supplemental Material

Supplemental material for this article is available online.

References

Bridgland

VME

Moeck

Green

, et al. Why the COVID-19 pandemic is a traumatic stressor. PLoS One. 2021;16:e0240146.

Phelps

Sperry

LL.

Children and the COVID-19 pandemic. J Psychol Trauma. 2020;12:S73-S75.

Sanchez-Gomez

Giorgi

Finstad

, et al. COVID-19 pandemic as a traumatic event and its associations with fear and mental health: a cognitive-activation approach. Int J Environ Res Public Health. 2021;18:7422.

Benfante

Di Tella

Romeo

Castelli

Traumatic stress in healthcare workers during COVID-19 pandemic: a review of the immediate impact. Front Psychol. 2020;11:2816.

Horesh

Brown

AD.

Traumatic stress in the age of COVID-19: a call to close critical gaps and adapt to new realities. J Psychol Trauma. 2020;12:331-335.

Hassett-Walker

Recovering individuals’ feelings about addict and alcoholic as stigmatized terms: implications for treatment. Subst Abuse. 2023;17:1-9.

Hamel

Kearney

Kirzinger

, et al. KFF Health Tracking Poll. July 27 2020. Accessed June 20, 2024. https://www.kff.org/coronavirus-covid-19/report/kff-health-tracking-poll-july-2020/

Chacon

Walia

Allen

, et al. Substance use during COVID-19 pandemic: impact on the underserved communities. Discoveries. 2021;9:e141.

Ali

Russell

Nafeh

, et al. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237.

10.

Dror

Eisenbach

Taiber

, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35:775-779.

11.

Saloner

Krawczyk

Solomon

, et al. Experiences with substance use disorder treatment during the COVID-19 pandemic: findings from a multistate survey. Int J Drug Policy. 2022;101:1-8.

12.

Avena

Simkus

Lewandowski

Gold

Potenza

MN.

Substance use disorders and behavioral addictions during the COVID-19 pandemic and COVID-19-related restrictions. Front Psychiatry. 2021;12:1-7.

13.

Hulsey

Mellis

Kelly

COVID-19 pandemic impact on patients, families and individuals in recovery from substance use disorders. Addict Policy Forum. 2020;May.

14.

Sinclair

Vanderplasschen

Savahl

, et al. Substitute addictions in the context of the COVID-19 pandemic. J Behav Addict. 2020;9:1098-1102.

15.

Chiappini

Guirguis

John

Corkery

Schifano

COVID-19: the hidden impact on mental health and drug addiction. Front Psychol. 2020;11:767.

16.

Martinotti

Alessi

Di Natale

, et al. Psychopathological burden and quality of life in substance users during the COVID-19 lockdown period in Italy. Front Psychol. 2020;11:896.

17.

Volkow

ND.

Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173:61-62.

18.

Mead

Hilton

Curtis

Peer support: a theoretical perspective. Psychiatr Rehabil J. 2001;25:134-141.

19.

Walker

Bryant

Peer support in adult mental health services: a metasynthesis of qualitative findings. Psychiatr Rehabil J. 2013;36:28-34.

20.

Smith

Carter

Walklet

Hazell

Investigating the experiences of individuals in recovery from problem substance use and their perceptions of the COVID-19 pandemic. Drugs Alcohol Today. 2022;22:17-27.

21.

Ornell

Moura

Scherer

, et al. The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment. Psychiatry Res. 2020;289:1-2.

22.

Jemberie

Stewart Williams

Eriksson

, et al. Substance use disorders and COVID-19: multi-faceted problems which require multi-pronged solutions. Front Psychiatry. 2020;11:714.

23.

Rodríguez

Colgan

Leyde

, et al. Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain. Subst Abuse Treat Prev Policy. 2024;19:25.

24.

Farley

Golding

Young

Mulligan

Minkoff

JR.

Trauma history and relapse probability among patients seeking substance abuse treatment. J Subst Abuse Treat. 2004;27:161-167.

25.

Gielen

Krumeich

Tekelenburg

Nederkoorn

Havermans

RC.

How patients perceive the relationship between trauma, substance abuse, craving, and relapse: a qualitative study. J Subst Use. 2016;21:466-470.

26.

Michaels

Stone

Singal

, et al. Brain reward circuitry: the overlapping neurobiology of trauma and substance use disorders. World J Psychiatry. 2021;11:222-231.

27.

Hassett-Walker

The longitudinal impact of arrest, criminal conviction, and incarceration on smoking classes. Tob Use Insights. 2022;15:1-12.

28.

Hennink

Kaiser

Marconi

VC.

Code saturation versus meaning saturation: how many interviews are enough?

Qual Health Res. 2017;27:591-608.

29.

Rural Health Resources for States from the Rural Health Information Hub. 2023-23. Accessed July 3, 2023. https://www.ruralhealthinfo.org/states

30.

Briere

Elliott

Harris

Cotman

Trauma symptom inventory. J Interpers Violence. 1995;10:387-401.

31.

https://traumareliefunlimited.com/TRU-Method-Effectiveness.html

32.

Raskind

Shelton

Comeau

, et al. A review of qualitative data analysis practices in health education and health behavior research. Health Educ Behav. 2019;46:32-39.

33.

Pope

Ziebland

Mays

Qualitative research in health care: analysing qualitative data. BMJ. 2000;320:114-116.

34.

Miles

Huberman

AM.

Qualitative Data Analysis: An Expanded Sourcebook. Sage; 1994.

35.

Elo

Kyngäs

The qualitative content analysis process. J Adv Nurs. 2008;62:107-115.

36.

Miller

JC.

12-Step treatment for alcohol and substance abuse revisited: best available evidence suggests lack of effectiveness or harm. Int J Ment Health Addict. 2008;6:568-576.

37.

Bøg

Filges

Brännström

Jørgensen

Fredrikksson

MK.

12-step programs for reducing illicit drug use. Campbell Syst Rev. 2017;13:1-49.

38.

https://nida.nih.gov/nidamed-medical-health-professionals/health-professions-education/words-matter-terms-to-use-avoid-when-talking-about-addiction

39.

Fiorentine

After drug treatment: are 12-step programs effective in maintaining abstinence?

Amer J Drug Alc Abuse. 1999;25:93-116.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

0.03 MB

0.11 MB